RWDD3 Antibody

ProSci
Product Code: PSI-5409
Product Group: Primary Antibodies
Supplier: ProSci
CodeSizePrice
PSI-5409-0.02mg0.02mg£150.00
Quantity:
PSI-5409-0.1mg0.1mg£449.00
Quantity:
Prices exclude any Taxes / VAT

Overview

Host Type: Rabbit
Antibody Isotype: IgG
Antibody Clonality: Polyclonal
Regulatory Status: RUO
Applications:
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Western Blot (WB)

Images

1 / 1
Western blot analysis of RWDD3 in mouse kidney tissue lysate with RWDD3 antibody at 0.5 μg/mL in (A) the absence and (B) the presence of blocking peptide.

Western blot analysis of RWDD3 in mouse kidney tissue lysate with RWDD3 antibody at 0.5 μg/mL in (A) the absence and (B) the presence of blocking peptide.

Further Information

Additional Names:
RWDD3 Antibody: RSUME, RSUME, RWD domain-containing protein 3, RWD-containing sumoylation enhancer
Application Note:
RWDD3 antibody can be used for detection of RWDD3 by Western blot at 0.5 μg/mL.

Antibody validated: Western Blot in mouse samples. All other applications and species not yet tested.
Background:
RWDD3 Antibody: RWDD3 (RSUME), a small RWD-containing protein, has a central role in sumoylation by enhancing SUMO conjugation in the regulatory network of immune-inflammatory signals. RWDD3 increases IκBeta sumoylation and stability. In addition, RWDD3 inhibits TNF-α-induced kappaB-LUC (Luciferase) reporter activity, showing the functional consequence of IκBeta increased stability. RSUME-enhanced sumoylation of IκBeta leads to the inhibition of NF-κBeta activity on two well-known inflammatory genes, IL-8 and cyclooxygenase-2 (Cox-2) and therefore may also favor anti-inflammatory pathways. Expression of RWDD3 was induced under hypoxic conditions and it has a potential role during vascularization. Both BMP-4 and RWDD3 may be interesting targets for inhibiting steps involved in pituitary tumorigenesis.
Background References:
  • Carbia-Nagashima A, Gerez J, Perez-Castro C, et al. RSUME, a small RWD-containing protein, enhances SUMO conjugation and stabilizes HIF-1alpha during hypoxia. Cell2007; 131:309-23.
  • Liberman AC, Druker J, Garcia FA, et al. Intracellular molecular signaling. Basis for specificity to glucocorticoid anti-inflammatory actions. Ann. NY Acad. Sci.2009; 1153:6-13.
  • Giacomini D, Haedo M, Gerez J, et al. Differential gene expression in models of pituitary prolactin-producing tumoral cells. Horm. Res.2009; 71 Suppl 2:88-94.
Buffer:
RWDD3 Antibody is supplied in PBS containing 0.02% sodium azide.
Concentration:
1 mg/mL
Conjugate:
Unconjugated
DISCLAIMER:
Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only.
Homology:
Predicted species reactivity based on immunogen sequence: Bovine: (81%)
Immunogen:
RWDD3 antibody was raised against a 17 amino acid synthetic peptide from near the amino terminus of human RWDD3.

The immunogen is located within the first 50 amino acids of RWDD3.
NCBI Gene ID #:
25950
NCBI Official Name:
RWD domain containing 3
NCBI Official Symbol:
RWDD3
NCBI Organism:
Homo sapiens
Physical State:
Liquid
Protein Accession #:
NP_056300
Protein GI Number:
153252154
Purification:
RWDD3 Antibody is affinity chromatography purified via peptide column.
Research Area:
Innate Immunity
Swissprot #:
Q9Y3V2
User NOte:
Optimal dilutions for each application to be determined by the researcher.

Related Products

Product NameProduct CodeSupplier 
RWDD3 PeptidePSI-5409PProSci Summary Details